Latest broker research reports
with
buy recommendations along with share price targets forecast and upside.
Browse thousands of reports and search by company.
Broker Research reports: Buy reports
for all stocks
Overall, the company aims to double its GWP and triple its PAT by FY28. We estimate STARHEAL to deliver FY26E combined ratio/RoE of 94.9%/17.0%. We reiterate our BUY rating with a TP of INR730.
PI Industries has offered to acquire UK based listed company Plant Health Care Plc (PHC) for a sum of £32.8 million which is in the agriculture biological space. It has experience in protein/peptide technology.
We maintain a Buy on Hindustan Unilever Limited (HUL) with an unchanged PT of Rs. 2,725. Likely revival in rural India and its underperformance versus broader indices makes HUL a preferred pick in the consumer goods space. Stock trades at 53x and 47x its FY25E and FY26E EPS, respectively
GPL reported its highest ever pre-sales of INR225b in FY24, up 84% YoY (61% higher than guidance), becoming the largest developer in terms of bookings.
Management demonstrated EPLL’s manufacturing efficiencies that are driven by the implementation of automation across machinery. Automation has been the key focus area across processes for the company.